Company Profile · Healthcare

Embecta Corp

EMBC · US
Country
USA
IPO date
Apr 1, 2022
Employees
1,850
Buffett Score
71/100
Strong
Market cap$328.06M
Revenue (TTM)$1.02B
EBITDA$281.5M
Profit margin8.59%
ROE0%
P/E (TTM)3.94
Forward P/E0
EPS$1.47
Dividend yield8.13%
52-week range$2.76 – $14.43
Analyst target$4.00
Analyst rating2.8 / 5

Data from EODHD, shown in the reporting currency; for reference only, not investment advice.

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

History

Coming soonThis section is being filled in — check back soon.

Industry position

Coming soonThis section is being filled in — check back soon.

No reports on this stock in your language yet.